Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pediatric asthma safety and efficacy study of fluticasone propionate + salmeterol versus fluticasone propionate
NL-OMON37737Phase 4Withdrawn
- Sponsor
- GSK
- Start
- Jun 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in persistent asthma comparing Fluticasone propionate with Fluticasone propionate + salmeterol (2 arms). Primary endpoints: Composite serious asthma-related outcomes and Asthma exacerbations. Planned start Jun 2012; status: withdrawn.
02
Drugs
fluticasone propionatesalmeterol
03
Conditions
persistent asthma
Beyond the preview
Go deeper on NL-OMON37737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37737.